Auteurs

Matthew Royle, Ph.D.

Associé

Read More

Dr. Manja Epping

Associé

Read More

Evelyne Friedel

Associé

Read More
Auteurs

Matthew Royle, Ph.D.

Associé

Read More

Dr. Manja Epping

Associé

Read More

Evelyne Friedel

Associé

Read More

30 septembre 2019 | 55:41

Biosimilars – Clearing the way for launch

In the third webinar of our series exploring the key differences between US and Europe biosimilars litigation and regulation, our experts discuss strategies for clearing the way to an early launch of a biosimilar.

Many of the top-selling drugs worldwide are biologics, and several companies are seeking to produce biosimilars to compete in these lucrative markets.

There are an increasing number of biologics reaching the end of their primary patent protection, and these companies must navigate the landscape of secondary patent protection in order to launch their biosimilars.

The strategies for doing so differ in the US and Europe, and there are different tools available.

Session 3 of this series focuses on strategic options for securing an early launch of a biosimilar, in particular:

  • devising a strategy to clear the way in Europe
  • so-called Arrow declarations may be available to provide a defence to any pending patent applications
  • Devising a strategy to clear the way in the US.
Call To Action Arrow Image

Latest insights in your inbox

Subscribe to newsletters on topics relevant to you.

Subscribe
Subscribe

Related Insights

Sciences de la vie et Santé

Biologics and biosimilars litigation update

25 novembre 2020
Quick read

par Matthew Royle, Ph.D. et Dr. Nora E. Wessendorf, LL.M. (Washington)

Cliquer ici pour en savoir plus
centrifuge-machine
Sciences de la vie et Santé

Dissecting the Regeneron v Kymab mouse case – what it says and its impact on patents

27 juillet 2020
QUICK READ

par plusieurs auteurs

Cliquer ici pour en savoir plus
woman-with-scientific-model
Sciences de la vie et Santé

Everything biologic and biosimilar in-house counsel need to know about COVID-19

29 avril 2020

par plusieurs auteurs

Cliquer ici pour en savoir plus

Événements connexes